Medicus Pharma LTD 8-K filings

NASDAQ

20 Mar 2025

MDCX

8-K: Medicus Pharma Sets Date for Annual and Special Shareholder Meeting

Medicus Pharma Ltd. announces its annual and special meeting of shareholders to be held on May 22, 2025, with a record date of April 22, 2025.

NASDAQ

11 Mar 2025

MDCX

Medicus Pharma LTD

8-K: Medicus Pharma Closes $4.2 Million Regulation A Offering to Fund Skin Cancer Clinical Trials

Medicus Pharma Ltd. successfully closed a $4.2 million Regulation A offering to advance its clinical trials for basal cell carcinoma treatment.

NASDAQ

11 Feb 2025

MDCX

Medicus Pharma LTD

8-K: Medicus Pharma Secures $15 Million Standby Equity Purchase Agreement and Plans TSXV Delisting

Medicus Pharma Ltd. enters into a Standby Equity Purchase Agreement with YA II PN, LTD for up to $15 million and announces its intention to voluntarily delist from the TSX Venture Exchange.